Biden’s Win Is Huge for These 2 Cannabis Stocks

These 2 cannabis stocks could skyrocket if Biden does what many are hoping he’ll do.

| More on:
Cannabis stocks have fallen.

U.S.President-Elect Joe Biden is ready to be sworn in on January 20. Investors might be asking the question: which stocks will benefit from this change in leadership?

I have two cannabis picks for investors asking these important questions.

Legalization could actually happen south of the border

The Democratic Party consists of a large number of individuals spanning the left-wing spectrum. Some Democrat leaders have publicly supported the idea of legalizing marijuana. More moderate leaders do not support of the idea. Joe Biden was elected as a democratic candidate with a more moderate view, so many speculate legalizing marijuana is low on his priority list right now (if it’s even on there). Given the problems the country has with the coronavirus pandemic, I wouldn’t expect any news soon.

That said, should we enter some level of normalcy sometime soon, cannabis legalization could come up for discussion. The Canadian cannabis sector is one which is being driven by growth prospects in the U.S. Accordingly, any positive news on legalization would likely cause hysteria much like we saw in 2018.

For those willing to speculate, my top two picks for investors to consider right now are Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) and Aphria Inc. (TSX:APHA)(NYSE:APHA).


Canopy holds the mantle of being the most investible cannabis stock out there, for a number of reasons. The company has not engaged in a big way in the hype-related M&A activity in 2018 and 2019 when stock prices were sky-high. Rather, this company has focused on lowering costs and increasing market share in its core businesses as well as growth sectors.

A large investment from Constellation Brands, one of the largest U.S. alcoholic beverage behemoths, has positioned Canopy well for growth in the cannabis-infused beverage business. Constellation’s U.S. operations are also a leg up in terms of distribution and cross-border issues other Canadian competitors have.

This company’s stock price has been less volatile than its peers. I think this is due to the more mature nature of this company relative to the more “junior” smaller-cap plays on the TSX.


Aphria has recently agreed to merge with Tilray Inc, whose U.S. exposure is something that investors have cheered perhaps more than anything in this merger. The company recently announced an acquisition of a brewer out of Atlanta with distribution in 27 states for US$300 million. Competition in the cananbis-infused beverage and cannabis 2.0 products segment is heating up. Accordingly, Aphria’s hopes to compete have increased substantially as a result of this merger.

The combined entity will have the firepower to compete with Canopy and grow market share in the U.S. potentially at a faster rate than Canopy presently. Potential risks around the deal falling through do exist, so trade carefully.

Bottom line

The likelihood of such a scenario ought to be considered. Cannabis legalization in the U.S. remains a long-shot. That said, investors seem to be pricing some likelihood into cannabis prices. The entire sector has seen a sharp spike post-election, largely pricing in these hopes. Investors looking for the next hot sector to bet on ought to consider these two plays on U.S. legalization.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Constellation Brands.

More on Cannabis Stocks

Upwards momentum
Energy Stocks

3 Canadian Stocks That Could be Huge Winners in the Next Decade and Beyond

Stocks like Canopy Growth, Blackberry, and Ballard Power are leading and redefining new multi-billion dollar industries.

Read more »

A cannabis plant grows.
Cannabis Stocks

Should You Invest in Canadian Cannabis Stocks Like Canopy Growth in September?

Canadian cannabis stocks, including Canopy Growth, remain high-risk bets for investors, despite trading 94% below all-time highs.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

ACB Stock: What’s Behind Aurora Cannabis’ Recent Surge?

More countries are legalizing marijuana. Should you buy ACB stock?

Read more »

data analytics, chart and graph icons with female hands typing on laptop in background
Cannabis Stocks

Got $5,000? 3 Stocks to Hold for the Next 20 Years

Long-term investors can consider buying shares of Dollarama and Curaleaf to generate market-beating gains in the next two decades.

Read more »

A cannabis plant grows.
Cannabis Stocks

Is Now the Time to Buy Cannabis Stocks?

These cannabis stocks are up 70% and 19% this month! Should Canadian investors hop on board?

Read more »

A cannabis plant grows.
Cannabis Stocks

Why I’m Considering Canopy Growth Stock For My RRSP

As the cannabis industry grows, adding Canopy Growth stock to my RRSP will give me access to massive upside.

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock Jumps 20%: Here’s What Happened

Canopy Growth stock (TSX:WEED)(NASDAQ:CGC) popped 20% on Monday from an announcement made by another cannabis producer.

Read more »

Retirement plan
Dividend Stocks

4 Stocks That Could Turn $100,000 Into $500,000 by the Time You Retire

Companies such as Brookfield Asset Management have the potential to consistently beat the broader markets and deliver stellar returns to…

Read more »